skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Anti-LPS antibodies reduce endotoxemia in whole body Co-60 irradiated primates - A preliminary report

Journal Article · · Aviation, Space and Environmental Medicine; (USA)
OSTI ID:6320539

A previously established primate model was used to evaluate the role of lipopolysaccharide (LPS, endotoxin) in radiation sickness. Vervet monkeys were Co-60 irradiated with an LD100 exposure and had periodic blood samples taken for the determination of LPS and anti-LPS lgG antibodies and for bacteriological studies. On day 2 postirradiation, primates were treated with either sterile 0.9 percent saline, or equine anti-LPS hyperimmune plasma, or tripotassium-dicitrato-bismuthate (Denol). Results indicate that anti-LPS-treated animals survived significantly longer than both the other groups and, since LPS may cause nausea, vomiting, diarrhea, anorexia, and headaches, it is suggested that Anti-LPS administration may be of value in reducing plasma LPS concentration in humans and improving their performance and survivability. 24 refs.

OSTI ID:
6320539
Journal Information:
Aviation, Space and Environmental Medicine; (USA), Vol. 61; ISSN 0095-6562
Country of Publication:
United States
Language:
English